A股收評:三大指數升跌不一!煤炭、文化傳媒及消費電子等板塊升幅居前
A股主要指數今日小幅震盪,截至收盤,滬指升0.31%報3037點,深證成指升0.08%,創業板指跌0.44%。近4000股上升,全天成交6919億元。盤面上,文化傳媒板塊走高,榮信文化等多股升停;北方高温來襲,煤炭板塊上揚,中國神華、陝西煤業股價雙雙刷新歷史高點;消費電子產業鏈全線走強,蘋果概念股領升,海能實業、得潤電子等多股升停;消息稱涉藥明系的HR8333提案在納入NDAA立法過程中受阻,CRO板塊拉昇,藥明康德一度升超8%;AIPC、影視概念及網絡遊戲等板塊升幅居前。另外,草甘膦板塊走低,華邦健康跌近4%;航運港口板塊持續走弱,ST錦港跌停;銀行、供銷社概念等跌幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.